Podnosis The business case for investing in women’s health
Women make up half the U.S. population and make most healthcare decisions. Yet only 2% of VC dollars go toward women’s health. A recent report, released at this year’s J.P. Morgan Healthcare Conference, lays out the high-growth potential of the women’s health market and its promised return on investment.
The report was published by nonprofit Women’s Health Access Matters (WHAM) and KPMG. Fierce Healthcare’s Anastassia Gliadkovskaya speaks to two leaders involved: Carolee Lee, founder of WHAM, and KPMG U.S. healthcare sector leader Ash Shehata. They walk through the details of the report’s findings and explain how the investment community is increasingly rallying around women’s health.
Read the full report here.
To learn more about the topics in this episode:
-
JPM25: First Lady Jill Biden committed to improving women's health as White House tenure winds down
-
New collective of women's health companies aims to scale access to specialty care
-
HHS announces $27.5M in funding to address women's behavioral health needs
See omnystudio.com/listener for privacy information.